Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun 1;42(2):e535-e536.
doi: 10.1097/WNO.0000000000001377. Epub 2021 Oct 22.

Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?

Lynn K Gordon  1 , Alfredo A Sadun  2 , Greg Van Stavern  3 , Andrew G Lee  4
Affiliations
Comment

Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?

Lynn K Gordon et al. J Neuroophthalmol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Comment on

  • Trial of Tocilizumab in Giant-Cell Arteritis.
    Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N. Stone JH, et al. N Engl J Med. 2017 Jul 27;377(4):317-328. doi: 10.1056/NEJMoa1613849. N Engl J Med. 2017. PMID: 28745999 Clinical Trial.
  • Comments on Tocilicizumab Use in Giant Cell Arteritis.
    Donaldson L, Zaslavsky K, Margolin E. Donaldson L, et al. J Neuroophthalmol. 2022 Jun 1;42(2):e534-e535. doi: 10.1097/WNO.0000000000001371. Epub 2021 Oct 21. J Neuroophthalmol. 2022. PMID: 34803143 No abstract available.

References

    1. Sadun A, Gordon L. Should tocilizumab be used routinely in new patients with a diagnosis of giant cell arteritis? J Neuroophthalmol. 2020;40:117–121.
    1. Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377:317–328.

MeSH terms